文献速递血液净化与透析

血液透析患者瘙痒的患病率、患者负担与医生认知

Prevalence, patient burden and physicians' perception of pruritus in haemodialysis patients.
PubMed 文献 · Nephrol Dial Transplant · 2024-01-01

该研究基于奥地利透析与移植登记处,对962例血液透析患者使用经验证问卷评估慢性肾脏病相关瘙痒(CKD-aP)的患病率、生活质量影响及危险因素,并调查医生认知与治疗方式。轻度、中度、重度瘙痒患病率分别为34.4%、11.4%、4.3%,中重度瘙痒与生活质量受损相关,危险因素包括较高C反应蛋白(OR 1.61)和甲状旁腺激素(OR 1.50)。

要点

  • 962例血液透析患者中轻度、中度、重度瘙痒患病率分别为34.4%、11.4%、4.3%。
  • 中重度瘙痒危险因素为较高C反应蛋白(OR 1.61)和甲状旁腺激素(OR 1.50)。
  • CKD-aP严重程度与生活质量受损显著相关,医生对瘙痒认知度高。

核心结论

  • 研究人群中CKD-aP总体患病率与既往文献相似,但中重度瘙痒患病率较低。
  • CKD-aP与生活质量下降及炎症标志物和甲状旁腺激素升高相关。
  • 奥地利肾脏科医生对CKD-aP的高认知度可能解释较严重瘙痒患病率较低。

研究设计与样本

  • 研究采用经验证的患者与医生瘙痒严重程度及生活质量问卷,结合奥地利透析与移植登记处信息。
  • 观察了962例血液透析患者。

主要发现

  • 962例观察患者中轻度、中度、重度瘙痒患病率分别为34.4%、11.4%、4.3%。
  • 医生估计的患病率分别为25.0%(95% CI 16.8-33.2)、14.4%(95% CI 11.3-17.6)和6.3%(95% CI 4.9-8.3)。
  • 从观察患者外推的全国估计患病率:任何程度瘙痒45.0%(95% CI 39.5-51.2),中度13.9%(95% CI 10.6-17.2),重度4.2%(95% CI 2.1-6.2)。
  • CKD-aP严重程度与生活质量受损显著相关。
  • 中重度瘙痒的危险因素为较高C反应蛋白(OR 1.61,95% CI 1.07-2.43)和甲状旁腺激素(OR 1.50,95% CI 1.00-2.27)。

关键数值与推荐

  • 轻度瘙痒患病率34.4%,中度11.4%,重度4.3%(962例观察患者)。
  • 医生估计轻度、中度、重度患病率分别为25.0%(95% CI 16.8-33.2)、14.4%(95% CI 11.3-17.6)、6.3%(95% CI 4.9-8.3)。
  • 全国外推估计任何程度瘙痒45.0%(95% CI 39.5-51.2),中度13.9%(95% CI 10.6-17.2),重度4.2%(95% CI 2.1-6.2)。
  • 中重度瘙痒危险因素:C反应蛋白OR 1.61(95% CI 1.07-2.43),甲状旁腺激素OR 1.50(95% CI 1.00-2.27)。

临床怎么用

  • 大多数中心对CKD-aP的治疗包括调整透析方案、局部治疗、抗组胺药、加巴喷丁和普瑞巴林及光疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic kidney disease-associated pruritus (CKD-aP) is an underrated symptom in patients with impaired kidney function. The present study assessed the prevalence, impact on quality of life (QoL) and risk factors for CKD-aP in a contemporary national cohort of patients on haemodialysis. In addition, we evaluated attending physicians' awareness and approach to therapy. METHODS: Validated patient's and physician's questionnaires on pruritus severity and QoL were used in combination with information obtained by the Austrian Dialysis and Transplant Registry. RESULTS: The prevalence of mild, moderate and severe pruritus in 962 observed patients was 34.4%, 11.4% and 4.3%. Physicians' estimated prevalence values were 25.0 (95% CI 16.8-33.2), 14.4 (11.3-17.6) and 6.3% (4.9-8.3), respectively. The estimated national prevalence estimate extrapolated from the observed patients was 45.0% (95% CI 39.5-51.2) for any, 13.9% (95% CI 10.6-17.2) for moderate and 4.2% (95% CI 2.1-6.2) for severe CKD-aP. CKD-aP severity was significantly associated with impaired QoL. Risk factors for moderate-severe pruritus were higher C-reactive protein [odds ratio (OR) 1.61 (95% CI 1.07-2.43)] and parathyroid hormone (PTH) values [OR 1.50 (95% CI 1.00-2.27)]. Therapy for CKD-aP included changes in the dialysis regimen, topical treatments, antihistamines, gabapentin and pregabalin and phototherapy in a majority of centres. CONCLUSIONS: While the overall prevalence of CKD-aP in our study is similar to that in previously published literature, the prevalence of moderate-severe pruritus is lower. CKD-aP was associated with reduced QoL and elevated markers of inflammation and PTH. The high awareness of CKD-aP in Austrian nephrologists may explain the lower prevalence of more severe pruritus.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Engler F, Kerschbaum J, Keller F, et al. Prevalence, patient burden and physicians' perception of pruritus in haemodialysis patients. Nephrol Dial Transplant. 2024. PMID: 37429597. doi:10.1093/ndt/gfad152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。